DCP Capital is a China-based private equity firm that invests in growth-oriented companies in Asia. The firm was founded in 2007 by David Liu and Julian Wolhardt, who previously worked at KKR and Morgan Stanley.
DCP Capital’s investment strategy is focused on the following key areas:
- Technology: DCP Capital invests in companies that are developing or using cutting-edge technologies. The firm believes that technology is a key driver of growth in Asia, and it is committed to investing in companies that are at the forefront of technological innovation.
- Consumer: DCP Capital invests in companies that are providing products or services to consumers in Asia. The firm believes that the Asian consumer market is one of the most dynamic in the world, and it is committed to investing in companies that are meeting the needs of this growing market.
- Healthcare: DCP Capital invests in companies that are providing healthcare products or services in Asia. The firm believes that the Asian healthcare market is one of the fastest-growing in the world, and it is committed to investing in companies that are improving the quality of healthcare in Asia.
DCP Capital typically invests between $50 and $250 million per deal in majority and minority transactions. The firm has a long-term investment horizon of up to 10 years, and it provides hands-on support to its portfolio companies to help them achieve their growth ambitions.
Here are some of the key benefits that DCP Capital offers to its portfolio companies:
- Access to capital: DCP Capital provides its portfolio companies with access to the capital they need to grow their businesses.
- Industry expertise: DCP Capital’s team has a deep understanding of the technology, consumer, and healthcare sectors in Asia. This expertise can help portfolio companies to develop and implement growth strategies.
- Global network: DCP Capital has a global network of contacts that can help portfolio companies to expand into new markets.
- Hands-on support: DCP Capital provides hands-on support to its portfolio companies to help them achieve their growth ambitions. This support can include strategic advice, operational assistance, and access to the firm’s network of contacts.
DCP Capital has a strong track record of success. The firm has invested in over 50 companies, and its portfolio companies have collectively generated over $10 billion in revenue. DCP Capital is a trusted partner for companies that are looking to grow their businesses in Asia.
Some of DCP Capital’s notable investments include:
- MFS Technology: A Singapore-based manufacturer of flexible printed circuit boards (FPCBs).
- Simple Love Yogurt: A Chinese yogurt company.
- Jamieson Wellness: A Canadian consumer health brand.
- American-Sino Healthcare: A leading premium private healthcare service provider in China.
- Hotwon Datacenter: A Chinese data center company.
